NormanJamesLacayoMD

Pediatric Hematology & Oncology • Palo Alto, CA

Bass Center for Childhood Cancer and Blood Disorders

Join to view full profile

Dr. Lacayo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lacayo's full profile

Already have an account?

Office
725 Welch Rd
Palo Alto, CA 94304
Phone+1 650-497-8000

Fax+1 650-497-8959

Education & Training

Stanford Health Care-Sponsored Stanford UniversityFellowship, Pediatric Hematology/Oncology, 1992 - 1995
University of California (San Francisco)Residency, Pediatrics, 1989 - 1992
University of California San Francisco School of MedicineClass of 1989

Certifications & Licensure

CA State Medical License 1991 - 2025
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Decitabine in Treating Children With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Start of enrollment: 2002 Dec 01
Terminated
Phase 1
Studying Biomarkers in Tissue Samples From Young Patients With Acute Myeloid Leukemia Previously Enrolled on Clinical Trial POG-9421 Start of enrollment: 2009 Oct 01
Completed
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL) Start of enrollment: 2011 Apr 14
Completed
Phase 1
Genome, Proteome and Tissue Microarray in Childhood Acute Leukemia Start of enrollment: 2001 Jul 01
Terminated
Biomarkers in Predicting Response to Treatment in Bone Marrow Samples From Young Patients With Acute Myeloid Leukemia Start of enrollment: 2011 Mar 01
Completed
Study to Predict Risk of Relapse in Bone Marrow Cell Samples From Younger Patients With Acute Myeloid Leukemia Start of enrollment: 2011 Sep 01
Completed
Genetic Test To Identify Previously Undetectable Minimal Residual Disease in Cell Samples From Younger Patients With Acute Lymphoblastic Leukemia Start of enrollment: 2012 Feb 01
Completed
A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2017 Jun 15
Active, not recruiting
Phase 2
Roles: Principal Investigator, Contact
Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children Start of enrollment: 2016 Feb 16
Completed
Phase 1
Roles: Contact, Principal Investigator
Protocol for Collecting, Banking and Distributing Human Tissue Samples: St. Jude Children's Research Hospital Tissue Resources Core Facility Start of enrollment: 2009 Sep 01
Recruiting
Roles: Contact, Principal Investigator
Expanded Access Program for Revumenib
Available
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Pharmacogenomic Score Effectively Personalizes Treatment of Acute Myeloid Leukemia.
Richard J Marrero, Huiyun Wu, Xueyuan Cao, Phani Krishna Parcha, Abdelrahman H Elsayed
Clinical Cancer Research. 2024-10-01
1 citations
AML/T cell interactomics uncover correlates of patient outcomes and the key role of ICAM1 in T cell killing of AML.
Ece Canan Sayitoglu, Bogdan A Luca, Allison Paige Boss, Benjamin Craig Thomas, Robert Arthur Freeborn
Leukemia. 2024-06-01
Pharmacogenomics, Race, and Treatment Outcome in Pediatric Acute Myeloid Leukemia.
Jatinder K Lamba, Richard Marrero, Huiyun Wu, Xueyuan Cao, Phani Krisha Parcha
JAMA Network Open. 2024-05-01

Abstracts/Posters

Establishing a Novel in Vitro Informed Precision Clinical Trial Pathway for Refractory Pediatric Leukemia
Norman J. Lacayo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Venetoclax in Combination with High-Dose Chemotherapy Is Active and Well-Tolerated in Children with Relapsed or Refractory Acute Myeloid LeukemiaClinically Relevant Ab...
Norman J. Lacayo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019